Celltrion Pharm, Inc.

KOSDAQ 068760.KQ

Celltrion Pharm, Inc. Total Assets for the year ending December 31, 2023: USD 492.78 M

Celltrion Pharm, Inc. Total Assets is USD 492.78 M for the year ending December 31, 2023, a 4.01% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Celltrion Pharm, Inc. Total Assets for the year ending December 31, 2022 was USD 473.78 M, a -11.26% change year over year.
Celltrion Pharm, Inc. Total Assets for the year ending December 31, 2021 was USD 533.91 M, a 6.12% change year over year.
Celltrion Pharm, Inc. Total Assets for the year ending December 31, 2020 was USD 503.13 M, a 23.93% change year over year.
Celltrion Pharm, Inc. Total Assets for the year ending December 31, 2019 was USD 405.99 M, a 0.37% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

KOSDAQ: 068760.KQ

Celltrion Pharm, Inc.

CEO	Jung-su Seo
IPO Date	Feb. 3, 2006
Location	South Korea
Headquarters	82, 2sandan-ro
Employees	888
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.

Key trends

Past 5 years